Apollomics Closes Private Placement
Ticker: APLMW · Form: 6-K · Filed: Sep 3, 2025 · CIK: 1944885
| Field | Detail |
|---|---|
| Company | Apollomics Inc. (APLMW) |
| Form Type | 6-K |
| Filed Date | Sep 3, 2025 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.01, $3.9317, $4.1 m, $114 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: private-placement, funding, sec-filing
TL;DR
Apollomics just closed a private placement, raising funds from investors.
AI Summary
On September 2, 2025, Apollomics Inc. entered into PIPE Subscription Agreements with certain accredited investors. The private placement, known as the PIPE, closed on September 3, 2025, with the issuance of PIPE shares to the purchasers.
Why It Matters
This private placement indicates Apollomics has secured additional funding from investors, which could support its ongoing operations and development of its pharmaceutical products.
Risk Assessment
Risk Level: medium — While the PIPE indicates investor confidence, the lack of specific financial details in this filing makes it difficult to assess the full impact on the company's financial health.
Key Players & Entities
- Apollomics Inc. (company) — Registrant
- September 2, 2025 (date) — Date of PIPE Subscription Agreements
- September 3, 2025 (date) — Closing date of the PIPE
FAQ
What is the total amount of capital raised in the PIPE?
The filing does not disclose the total amount of capital raised in the PIPE.
Who are the specific accredited investors that participated in the PIPE?
The filing refers to them as 'certain accredited investors' and 'Purchasers' but does not name them specifically.
What is the price per share for the PIPE shares?
The filing does not specify the price per share for the PIPE shares.
What will the proceeds from the PIPE be used for?
The filing does not detail the intended use of the proceeds from the PIPE.
Are there any lock-up periods or restrictions on the resale of the PIPE shares?
The filing does not mention any lock-up periods or resale restrictions for the PIPE shares.
Filing Stats: 1,757 words · 7 min read · ~6 pages · Grade level 11.9 · Accepted 2025-09-03 16:05:17
Key Financial Figures
- $0.01 — lion Class A ordinary shares, par value $0.01 per share, of the Company (the "PIPE Sh
- $3.9317 — "PIPE Shares"), at a price per share of $3.9317 (the closing price on August 29, 2025),
- $4.1 m — regate gross proceeds to the company of $4.1 million, prior to the payment of fees and
- $114 million — another series, and secured a total of $114 million USD within seven years. He also inked a
Filing Documents
- d56007d6k.htm (6-K) — 24KB
- d56007dex101.htm (EX-10.1) — 165KB
- 0001193125-25-194953.txt ( ) — 190KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. APOLLOMICS INC. Date: September 3, 2025 By: /s/ Howard Chen Name: Howard Chen Title: Chairman